Kyung Wan Nam

Title: Kyung Wan Nam: Innovator in Pharmaceutical Compositions

Introduction

Kyung Wan Nam is a notable inventor based in Gunpo, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of combination drugs aimed at treating cardiovascular diseases. With a total of 3 patents to his name, his work reflects a commitment to improving drug efficacy and safety.

Latest Patents

One of his latest patents is a pharmaceutical combination drug that includes fimasartan and rosuvastatin as active ingredients, along with meglumine. This innovative combination preparation demonstrates an outstanding effect in treating cardiovascular disease by enhancing disintegration and dissolution, which leads to improved drug bioavailability and safety. Another significant patent is a pharmaceutical composition containing fimasartan and hydrochlorothiazide. This invention provides a composition with superior physical properties, as both fimasartan and hydrochlorothiazide exhibit excellent content uniformity, along with a method for its preparation.

Career Highlights

Kyung Wan Nam is currently associated with Boryung Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts in the pharmaceutical sector. His work is characterized by a focus on creating effective and safe drug combinations that address critical health issues.

Collaborations

He collaborates with talented colleagues, including Je Hak Kim and Ju Won Kim, who contribute to the innovative environment at Boryung Pharmaceutical Co., Ltd. Their teamwork fosters a culture of creativity and scientific inquiry.

Conclusion

Kyung Wan Nam's contributions to pharmaceutical innovations highlight his dedication to improving healthcare through effective drug formulations. His patents reflect a significant impact on the treatment of cardiovascular diseases, showcasing the importance of collaboration and innovation in the pharmaceutical industry.